← boothcheck

EHC vs SHC stock comparison

Encompass Health Corporation vs Sotera Health Co, two Medical Care stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.

What is priced in: Sotera at 42.4 times earnings needs its sterilization moat to outrun 3.46 turns of debt; Encompass at 16.9 times needs inpatient rehab demand to keep filling hospitals it is still building. The economics run closer than the multiples, net margins of 9.9% and 10%, returns on equity of 18.9% and 18.4%, near mirrors. The differences are structural: Sotera's 52.5% gross margin niche against Encompass' operational model, Sotera's thin 1.9% free-cash yield against Encompass' construction-driven negative 7.2%. Twenty-five turns of premium for the moat over the operator, with neither currently paying cash for the wait; the pair prices patience twice, at very different rates.

Comparison updated 2026-07-10.

EHC vs SHC: the numbers

MetricEHCSHC
Price$101.30$17.38
Market cap$10.2B$5.0B
SectorMedical CareMedical Care
StageMatureMature
Implied growth (priced in)+8.8%+15.4%
P/E16.942.4
P/B3.088.03
P/S1.684.20
EV/EBITDA37.7271.2
Revenue growth+10.1%+7.5%
Gross margin52.5%
Net margin10.0%9.9%
Return on equity18.4%18.9%
Return on assets8.3%3.6%
FCF yield-7.2%1.9%
Dividend yield0.7%
Debt / equity0.783.46
Current ratio1.172.82
Altman Z (solvency)2.401.44
Piotroski F (quality)5 / 94 / 9
Full EHC report → Full SHC report →
Get boothcheck's read on EHC and SHC, and what their prices are betting on, in your inbox. No hype, no spam.
Free. Informational only, not investment advice. Unsubscribe anytime.

Compare any two stocks

vs

The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.